Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Robinson

Showing results (1101-1110 of 1,209) with videos related to

Pageof 121
Sort By:
Clinical Pharmacology and Therapeutics|July 4, 2013
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancerJ J Yang, J Y S Lim, J Huang, et al.
Radiology|May 14, 2024
Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for MedulloblastomaQing Ji, Samuel S McAfee, Matthew Scoggins, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastomaJingjing Liu, Xu Yang, Mingrui Zhu, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Developmental determinants of male bias in medulloblastomaLuca Bianchini, Ruijie Xu, David Filipovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisKevin Hollevoet, Johannes B Reitsma, Jenette Creaney, et al.
Neuro-Oncology|December 11, 2021
Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional studyJohn T Lucas, Christopher L Tinkle, Jie Huang, et al.
Oncogene|March 3, 2015
Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapyE Lau, J Sedy, C Sander, et al.
Nature Ecology & Evolution|October 3, 2022
Safeguarding nutrients from coral reefs under climate changeCamille Mellin, Christina C Hicks, Damien A Fordham, et al.
Neuro-Oncology Advances|October 2, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma WorkshopMarta Penas-Prado, Brett J Theeler, Brittany Cordeiro, et al.
Cancer Cell|April 2, 2014
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastomaMarie Morfouace, Anang Shelat, Megan Jacus, et al.
Pageof 121

Showing results (1101-1110 of 1,209) with videos related to

Sort By:
Pageof 121
Clinical Pharmacology and Therapeutics|July 4, 2013
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancerJ J Yang, J Y S Lim, J Huang, et al.
Radiology|May 14, 2024
Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for MedulloblastomaQing Ji, Samuel S McAfee, Matthew Scoggins, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastomaJingjing Liu, Xu Yang, Mingrui Zhu, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Developmental determinants of male bias in medulloblastomaLuca Bianchini, Ruijie Xu, David Filipovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisKevin Hollevoet, Johannes B Reitsma, Jenette Creaney, et al.
Neuro-Oncology|December 11, 2021
Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional studyJohn T Lucas, Christopher L Tinkle, Jie Huang, et al.
Oncogene|March 3, 2015
Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapyE Lau, J Sedy, C Sander, et al.
Nature Ecology & Evolution|October 3, 2022
Safeguarding nutrients from coral reefs under climate changeCamille Mellin, Christina C Hicks, Damien A Fordham, et al.
Neuro-Oncology Advances|October 2, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma WorkshopMarta Penas-Prado, Brett J Theeler, Brittany Cordeiro, et al.
Cancer Cell|April 2, 2014
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastomaMarie Morfouace, Anang Shelat, Megan Jacus, et al.
Pageof 121